Skip to main content

Animations

MJFF Publications

7151 - 7160 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2025
  • 2015
  • 2023
  • 2025
  • 2009
  • 2019
  • 2017
  • 2020
  • 2015
  • Summary Details
    OPEN
    Title: Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson’s Disease Patient
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells12040625
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Decreased SNCA expression in whole-blood RNA analysis of Parkinson’s disease adjusting for neutrophils
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-01062-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease 1
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: unspecified-oa
    DOI - Digital Object Identifier: 10.3233/jpd-150570
    Citation Count: 29
  • Summary Details
    RESTRICTED
    Title: Cognitive Predictors of Responsiveness to Reactive Step Training in People with Parkinson’s Disease at Fall-Risk
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2023.137517
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Heartbeat signature for predicting motor and non-motor involvement among nonparkinsonian LRRK2 G2019S mutation carriers
    Journal Name: Clinical Autonomic Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s10286-024-01104-6
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2009.04.010
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS
    Journal Name: Clinical Biochemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.clinbiochem.2019.05.006
    Citation Count: 34
  • Summary Details
    OPEN
    Title: The Systemic Synuclein Sampling Study: Toward a Biomarker for Parkinson’s Disease
    Journal Name: Biomarkers in Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.2217/bmm-2016-0366
    Citation Count: 52
  • Summary Details
    OPEN
    Title: TRIM11 Prevents and Reverses Protein Aggregation and Rescues a Mouse Model of Parkinson’s Disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2020.108418
    Citation Count: 60
  • Summary Details
    RESTRICTED
    Title: Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.007
    Citation Count: 37
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.